The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peng, Q.
Right arrow Articles by Zhou, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peng, Q.
Right arrow Articles by Zhou, W.
The Journal of Immunology, 2006, 176: 3330-3341.
Copyright © 2006 by The American Association of Immunologists

Dendritic Cell Synthesis of C3 Is Required for Full T Cell Activation and Development of a Th1 Phenotype1

Qi Peng, Ke Li, Hetal Patel, Steven H. Sacks and Wuding Zhou2

Department of Nephrology and Transplantation, King’s College London School of Medicine at Guy’s, King’s College and St. Thomas’ Hospitals, London, United Kingdom

Previous studies have found that deficiency of complement component C3 is associated with reduced T cell responses in several disease models including viral infection, autoimmune disease, and transplantation. However, the underlying mechanism is unclear. In this study, we demonstrate that dendritic cells (DCs) are able to synthesize C3 and this synthesis is required for the capacity of DCs to stimulate alloreactive T cell responses in vitro and in vivo. Compared with C3-producing DCs, C3-nonproducing DCs exhibit reduced potency to stimulate an alloreactive T cell response, favor the polarization of CD4+ T cells toward Th2 phenotype, and have regulatory T cell-driving capacity. In addition, priming mice with C3-deficient DCs compared with wild-type DCs led to delayed skin allograft rejection. Our findings that nonproduction of C3 by DCs significantly reduced T cell stimulation and impaired allograft rejection provide a potentially important explanation of how C3-deficient mice develop reduced T cell responses and of how C3-deficient donor kidney is protected from T cell-mediated graft rejection.




This article has been cited by other articles:


Home page
 Mol. Cell. ProteomicsHome page
C. Villiers, M. Chevallet, H. Diemer, R. Couderc, H. Freitas, A. Van Dorsselaer, P. N. Marche, and T. Rabilloud
From Secretome Analysis to Immunology: CHITOSAN INDUCES MAJOR ALTERATIONS IN THE ACTIVATION OF DENDRITIC CELLS VIA A TLR4-DEPENDENT MECHANISM
Mol. Cell. Proteomics, June 1, 2009; 8(6): 1252 - 1264.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. Baruah, I. E. Dumitriu, T. H. Malik, H. T. Cook, J. Dyson, D. Scott, E. Simpson, and M. Botto
C1q enhances IFN-{gamma} production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells
Blood, April 9, 2009; 113(15): 3485 - 3493.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. L. Mershon, A. Vasuthasawat, G. W. Lawson, S. L. Morrison, and D. O. Beenhouwer
Role of Complement in Protection against Cryptococcus gattii Infection
Infect. Immun., March 1, 2009; 77(3): 1061 - 1070.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Li, K. J. Anderson, Q. Peng, A. Noble, B. Lu, A. P. Kelly, N. Wang, S. H. Sacks, and W. Zhou
Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation
Blood, December 15, 2008; 112(13): 5084 - 5094.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Pavlov, H. Raedler, S. Yuan, S. Leisman, W.-h. Kwan, P. N. Lalli, M. E. Medof, and P. S. Heeger
Donor Deficiency of Decay-Accelerating Factor Accelerates Murine T Cell-Mediated Cardiac Allograft Rejection
J. Immunol., October 1, 2008; 181(7): 4580 - 4589.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Ghannam, M. Pernollet, J.-L. Fauquert, N. Monnier, D. Ponard, M.-B. Villiers, J. Peguet-Navarro, A. Tridon, J. Lunardi, D. Gerlier, et al.
Human C3 Deficiency Associated with Impairments in Dendritic Cell Differentiation, Memory B Cells, and Regulatory T Cells
J. Immunol., October 1, 2008; 181(7): 5158 - 5166.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Sacks and W. Zhou
New Boundaries for Complement in Renal Disease
J. Am. Soc. Nephrol., October 1, 2008; 19(10): 1865 - 1869.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Spirig, C. van Kooten, C. Obregon, L. Nicod, M. Daha, and R. Rieben
The Complement Inhibitor Low Molecular Weight Dextran Sulfate Prevents TLR4-Induced Phenotypic and Functional Maturation of Human Dendritic Cells
J. Immunol., July 15, 2008; 181(2): 878 - 890.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Q. Peng, K. Li, K. Anderson, C. A. Farrar, B. Lu, R. A. G. Smith, S. H. Sacks, and W. Zhou
Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction
Blood, February 15, 2008; 111(4): 2452 - 2461.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. N. Lalli, M. G. Strainic, F. Lin, M. E. Medof, and P. S. Heeger
Decay Accelerating Factor Can Control T Cell Differentiation into IFN-{gamma}-Producing Effector Cells via Regulating Local C5a-Induced IL-12 Production
J. Immunol., November 1, 2007; 179(9): 5793 - 5802.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.